日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Excessive reactive oxygen species attenuated IL-17 production in CD161(++) CD8(+) T cell subset via repression of FOS in HIV-infected immunological non-responders

过量的活性氧通过抑制 FOS 减弱 HIV 感染免疫无应答者 CD161(++) CD8(+) T 细胞亚群中 IL-17 的产生。

Li, Jia-Qi; Yang, Tian-Ling; Liu, Mei; Li, Si-Yao; Fu, Ya-Jing; Jiang, Yong-Jun; Shang, Hong; Zhang, Zi-Ning

Elevated Peripheral CD161(+) Treg Cells and Their Clinical Significance in Behçet Syndrome

外周血CD161(+) Treg细胞升高及其在白塞氏病中的临床意义

Li, Jiachen; Xia, Weiyi; Sun, Feng; Li, Yingni; Hou, Yuke; Ren, Huanhuan; Sun, Xiaolin; Li, Yuhui; Li, Zhanguo; Liu, Tian

Liver transplant-facilitated CD161+Vα7.2+ MAIT cell recovery demonstrates clinical benefits in hepatic failure patients

肝移植促进CD161+Vα7.2+ MAIT细胞恢复,对肝功能衰竭患者显示出临床益处。

Wei Wang # ,Chen Dai # ,Peng Zhu ,Mi Wu ,Haoquan Zhang ,Qing Wei ,Ting Zhou ,Xiaosheng Tan ,Ying Jiang ,Xue Cheng ,Zhihui Liang ,Xiongwen Wu ,Zhishui Chen ,Xiufang Weng

Targeting of the CD161 Inhibitory Receptor Enhances Bone-Marrow-Resident Memory CD8(+) T-Cell-Mediated Immunity against Multiple Myeloma.

靶向 CD161 抑制性受体可增强骨髓驻留记忆 CD8(+) T 细胞介导的抗多发性骨髓瘤免疫力。

Immune profiling identifies CD161+CD127+CD8+ T cells as a predictive biomarker for Anti-PD-L1 therapy response in the SCLC-I subtype

免疫谱分析发现 CD161+CD127+CD8+ T 细胞可作为 SCLC-I 亚型中抗 PD-L1 治疗反应的预测性生物标志物。

Jingjing Qu # ,Wenjia Sun # ,Yuekang Li # ,Ziwan Cai ,Binggen Wu ,Qian Shen ,Lijun Chen ,Bo Wang ,Lixiong Ying ,Chenchai Xie ,Jing Zheng ,Jianya Zhou ,Jianying Zhou

High tumor CD161 expression predicts a survival advantage and marks a Th1-skewed microenvironment

肿瘤中CD161高表达预示着生存优势,并标志着Th1型偏向的微环境。

Burns, Briana Amicarella; Chandra, Manasvi; Konduri, Vanaja; Decker, William K

Immunobiology roles of the human CD161 receptor in T cells

人类CD161受体在T细胞中的免疫生物学作用

Tong, Bainan; Wang, Mingxuan; Liu, Lu; Yang, Xinyue

Intrahepatic CD161(hi)CD8+T Cell Recruitment Has a Pathogenetic Potential in Chronic HBV Infection

肝内CD161(hi)CD8+T细胞募集在慢性乙型肝炎病毒感染中具有致病潜力

Li, Jianfei; Liu, Qian; Duan, Wanlu; Duan, Zhi; Liu, Futing; Ruan, Mengqi; Zong, Qiyin; Zhang, Hao; Zhou, Qiang; Wang, Qin

CD161, a promising prognostic biomarker in hepatocellular carcinoma, correlates with immune infiltration

CD161是肝细胞癌中一种有前景的预后生物标志物,与免疫浸润相关。

Wang, Jinfeng; Wang, Xiaoxiao; Shi, Jianfei; Wang, Yongjun; Mi, Lili; Zhao, Man; Han, Guangjie; Yin, Fei

Targeting of the CD161 inhibitory receptor enhances T-cell-mediated immunity against hematological malignancies

靶向 CD161 抑制性受体可增强 T 细胞介导的抗血液系统恶性肿瘤免疫力。

Alvarez Calderon, Francesca; Kang, Byong H; Kyrysyuk, Oleksandr; Zheng, Shiwei; Wang, Hao; Mathewson, Nathan D; Luoma, Adrienne M; Ning, Xiaohan; Pyrdol, Jason; Cao, Xuan; Suvà, Mario L; Yuan, Guo-Cheng; Wittrup, K Dane; Wucherpfennig, Kai W